London, United Kingdom, 18th December 2015 – The world’s pioneering researchers in robotic surgery are invited to showcase their innovative work by taking part in the Surgical Robot Challenge 2016. The Surgical Robot Challenge is open for entry from today, and the competition finals will be held from 20 – 27 June 2016 at the Hamlyn Symposium on Medical Robotics in London, as part of the first ever UK Robotics Week. Full details of the competition and how to enter can be found at: http://roboticsweek.uk/surgicalrobotchallenge.htm.
This international competition annually showcases cutting-edge advances in surgical robot technologies. Teams from around the world will be bringing their surgical robots to London in June to demonstrate their latest innovations. Each team will be given 3 hours to set up and demonstrate their technologies to an independent judging panel of leading surgeons and pioneers in the field, competing for a prize fund of 10,000 GBP.
Key Research on Technologies for Parkinson’s Disease Management Published in IEEE Journal of Biomedical and Health InformaticsSubmitted by neondrum on Mon, 11/02/2015 - 12:08
London, United Kingdom, 2nd November 2015 – The latest technology advances for the clinical management of Parkinson’s disease are explored in cutting-edge research published today by the IEEE’s Journal of Biomedical and Health Informatics (J-BHI). Authored by distinguished researchers in the field, the papers of the Special Issue on “Enabling Technologies for Parkinson’s Disease Management” are available to download now from the IEEE Xplore® Digital Library via http://jbhi.embs.org/
Parkinson’s disease is the most common neurological movement disorder, with a prevalence of up to 2% in the elderly. The new research published in this Special issue represents the edge between the current technical abilities of engineering solutions and clinical applications for the management of Parkinson’s disease, spanning wearable technologies and the Internet of Things, body sensor networks and smart home techniques.
Major New Papers on Big Data for Health Published in IEEE Journal of Biomedical and Health InformaticsSubmitted by neondrum on Fri, 07/24/2015 - 11:41
London, UK, 24th July 2015 – A major collection of papers exploring the very latest research and key developments in Big Data for health informatics has been published by the IEEE’s Journal of Biomedical and Health Informatics (J-BHI). Authored by research teams from the world’s leading institutions, the papers of the Special Issue on “Big Data for Health” are available to download now via the IEEE Xplore® Digital Library at http://jbhi.embs.org/2015/07/08/special-issue-big-data-for-health/
Scientists at The Scripps Research Institute (TSRI) have discovered that a brain protein has a key role in controlling binge drinking in animal models. They found that deleting the gene for this protein in mice ramped up alcohol consumption and prevented the brain from signaling the rewarding properties of alcohol.
"Alcohol hits a lot of different targets in our brain, which makes disentangling the in vivo effects of alcohol quite complicated," said TSRI biologist Candice Contet, senior author of the study. "Our study sheds light on the molecular mechanisms implicated in binge drinking."
Researchers have uncovered a unique connection between diabetes and Alzheimer's disease, providing further evidence that a disease that robs people of their memories may be affected by elevated blood sugar, according to scientists at Washington University School of Medicine in St. Louis.
While many earlier studies have pointed to diabetes as a possible contributor to Alzheimer's, the new study - in mice - shows that elevated glucose in the blood can rapidly increase levels of amyloid beta, a key component of brain plaques in Alzheimer's patients. The buildup of plaques is thought to be an early driver of the complex set of changes that Alzheimer's causes in the brain. The research is published May 4 in The Journal of Clinical Investigation.
A University of Cincinnati (UC)-led research team has found that generic formulations of tacrolimus, a drug used post-transplant to lower the risk of organ rejection, are just as good as the name-brand version.
The findings were presented Sunday, May 3, by lead investigator Rita Alloway, PharmD, UC research professor of medicine and director of transplant clinical research within the UC Department of Internal Medicine, and her study collaborators at the 2015 American Transplant Congress annual meeting in Philadelphia.